• Home
  • Blanver Farmoquimica Ltda.
6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 18D41
Book a meeting

Blanver Farmoquimica Ltda.

About Blanver Farmoquimica Ltda.

Blanver is a Brazilian pharmaceutical company with over 40 years of history and global experience.
As one of the most respected producers of Active Pharmaceutical Ingredients (APIs) and finished pharmaceutical products in Brazil, we develop, manufacture, and market high-quality treatments for HIV, Hepatitis C, Osteoporosis, Oncology, Hematology, and Rare Diseases.
Thanks to the versatility of our business models, we actively explore various forms of collaboration, including the licensing of innovative products and other commercial opportunities.

Read more Show less
Certifications
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 18D41
  • Country/Region:
    Brazil
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    250 - 499
Company types
Other
Contact info
Show contact info Hide contact info

Products from Blanver Farmoquimica Ltda. (8)

  • CILOSTAZOL

    Product CILOSTAZOL

    Antiplatelet Agents and vasodilator, Hematologic; Phosphodiesterase 3 (PDE3) Inhibitors; Phospholipase A2 Inhibitors; Antithrombotic.
  • Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

    Product Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

    - Presentation: Plastic bottles with 30 coated tablets.  

    - Indication (Brazil Prescription Medicines): 
    1) For PrEP® (pre-exposure prophylaxis), it can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices.
    ...
  • Raloxifene Hydrochloride 60 mg

    Product Raloxifene Hydrochloride 60 mg

    - Presentation: Blisters containing 28 film-coated tablets  

    - Indication (Brazil Prescription Medicines): 
    1) For the prevention and treatment of osteoporosis;
    2) To reduce the risk of breast cancer in postmenopausal womem with osteoporosis.

    -...
  • Tenofovir Disoproxil Fumarate

    Product Tenofovir Disoproxil Fumarate

    API - Active Pharmaceutical Ingredient

    - Therapeutic Area: HIV infection and Chronic Hepatitis B
    - Status: DMF (Drug Master File Ready) 

    Blanver fully respects the patents’ expiration dates in all countries
  • Tenofovir Disoproxil Fumarate 300 mg

    Product Tenofovir Disoproxil Fumarate 300 mg

    - Presentation: Package containing 60 plastic bottles with 30 coated tablets.

    - Indication (Brazil Prescription Medicines): First line medication indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults and chronic Hepatitis B.
    ...
  • Sofosbuvir 400 mg

    Product Sofosbuvir 400 mg

    - Presentation: Plastic bottles with 28 coated tablets.  

    - Indication (Brazil Prescription Medicines): indicated for the treatment of chronic hepatitis C Virus infection in adult patients, in combination with other antiviral agents.

    - Recommended Dosage: 1 tablet once a day...
  • Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg

    Product Tenofovir Disoproxil Fumarate 300 mg + Lamivudine 300 mg

    - Presentation: Plastic bottles with 30 coated tablets.

     - Indication (Brazil Prescription Medicines): Used with other HIV-1 medicines to treat HIV-1 infection. Its use can promote greater adherence to the treatment and also reduce the cost and number of pills taken daily.
    ...
  • Lithium Carbonate

    Product Lithium Carbonate

    API - Active Pharmaceutical Ingredient

    - Therapeutic Area: Bipolar Disorder and Major Depressive Disorder as adjunctive
    - Status: DMF (Drug Master File) ready

    Blanver fully respects the patents’ expiration dates in all countries*

Blanver Farmoquimica Ltda. Resources (1)